SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-185092
Filing Date
2022-06-29
Accepted
2022-06-29 16:33:06
Documents
5
Period of Report
2022-08-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A d320210ddef14a.htm DEF 14A 1200939
2 GRAPHIC g320210g15k16.jpg GRAPHIC 29671
3 GRAPHIC g320210g19e99.jpg GRAPHIC 26392
4 GRAPHIC g320210g88c34.jpg GRAPHIC 242930
5 GRAPHIC g320210g89d35.jpg GRAPHIC 340199
  Complete submission text file 0001193125-22-185092.txt   2075203
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37627 | Film No.: 221055056
SIC: 2834 Pharmaceutical Preparations